Clinical trial
Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled…
NCT00373048 · Institute of Tropical Medicine, Belgium, Other · Completed
Key facts
| NCT number | NCT00373048 |
|---|---|
| Title | Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial |
| Official title | Mefloquine Malaria Prophylaxis in HIV-1 Infected Individuals and Its Influence on the Evolution Towards AIDS: a Randomized Placebo-controlled Trial |
| Lead sponsor | Institute of Tropical Medicine, Belgium, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | mefloquine, placebo |
| Enrollment | 300 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | May 1, 2011 |
| First posted | Sep 7, 2006 |
| Last update posted | May 24, 2011 |
| Countries | Zambia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: